2. Two heads are better than one

Well, in this case, two companies are better than one. Pfizer and IBM are collaborating to develop a remote monitoring solution for patients with Parkinson’s disease. A system of sensors, mobile devices, and machine learning will produce a steady stream of information to be used by clinicians and researchers to adjust treatment decisions and learn more about the disease. Pfizer and IBM will be consulting with an advisory board comprised of patient groups, advocacy groups, clinicians, and researchers to help guide the program.  A remote monitoring solution of this kind will open new doors for data collection in patient care and clinical research.  More data. Fewer office visits. Faster and cheaper trials. Everybody wins.